Alnylam Competitors and Similar CompaniesClear all
Celyad's competitors and similar companies include CureVac.
 Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. | ||
Founding Date | Founding Date 2007 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Mont-Saint-Guibert, BE HQ New York, US | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US |
Employees | Employees 17 | Employees 999 |
Valuation ($) | Valuation ($) 11.8 m | Valuation ($) 648.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) €102k (FY, 2023) | Revenue (est.) €53.8m (FY, 2023) |
Cost of goods | Cost of goods €69k (FY, 2023) | Cost of goods €64.3m (FY, 2023) |
Gross profit | Gross profit €1.4m (FY, 2023) | Gross profit (€2.6m) (FY, 2023) |
Net income | Net income (€8.4m) (FY, 2023) | Net income (€260.2m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
999
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company